Elekta Instrument AB recalls
Elekta Instrument AB has 5 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 13 Nov 2024. 4 are still ongoing. The most frequent reason is foreign material.
Total recalls5since 2019
Last 12 months0reported
Class I240% of total
Ongoing4latest 13 Nov 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 40%Class II 3 60%Class III 0 0%
Why elekta instrument ab is recalled
Product types
By year
Ongoing elekta instrument ab recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS I | Elekta Disposable Biopsy Needle Kit for Leksell Stereotactic System recalled | Elekta Instrument AB | Foreign Material | 11 states |
| Device | CLASS I | Elekta Disposable Biopsy Needle Kit for Leksell Stereotactic System recalled | Elekta Instrument AB | Foreign Material | |
| Device | CLASS II | Instructions for Use for the following Leksell Stereotactic recalled | Elekta Instrument AB | Other | Nationwide |
| Device | CLASS II | Leksell GammaPlan recalled by Elekta Instrument AB | Elekta Instrument AB | Other | Nationwide |
All elekta instrument ab recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS I | Elekta Disposable Biopsy Needle Kit for Leksell Stereotactic System recalled | Elekta Instrument AB | Foreign Material | 11 states |
| Device | CLASS I | Elekta Disposable Biopsy Needle Kit for Leksell Stereotactic System recalled | Elekta Instrument AB | Foreign Material | |
| Device | CLASS II | Instructions for Use for the following Leksell Stereotactic recalled | Elekta Instrument AB | Other | Nationwide |
| Device | CLASS II | Leksell Vantage Stereotactic System recalled by Elekta Instrument AB | Elekta Instrument AB | Device Malfunction | 14 states |
| Device | CLASS II | Leksell GammaPlan recalled by Elekta Instrument AB | Elekta Instrument AB | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.